磷酸化乳腺癌抗雌激素耐药蛋白1抗体

磷酸化乳腺癌抗雌激素耐药蛋白1抗体

收藏
  • ¥1580
  • gelatins
  • jlcR6224
  • 国内
  • 2025年07月08日
  • WB,ELISA等
  • 人/动物/植物
avatar
  • 企业认证

    点击 QQ 联系

  • 万千商家帮你免费找货

    0 人在求购买到急需产品
    • 详细信息
    • 技术资料
    • 供应商

      江西江蓝纯生物试剂有限公司

    • 库存

      63

    • 克隆性

      单克隆

    • 保质期

      1年

    • 抗体英文名

      phospho-BCAR1 (Tyr410)

    • 抗体名

      磷酸化乳腺癌抗雌激素耐药蛋白1抗体

    • 适应物种

      人/动物/植物

    • 应用范围

      WB,ELISA等

    • 浓度

      1mg/ml

    • 保存条件

      -20 °

    • 规格

      100UL

    产品 :  jlcR6224
    英文名称 :  phospho-BCAR1 (Tyr410)
    中文名称 :  磷酸化乳腺癌抗雌激素耐药蛋白1抗体
       :  BCAR1 (phospho Y410); BCAR1(phospho Y410); p-BCAR1(p-Tyr410); Breast cancer anti estrogen resistance 1 protein; BCAR 1; Bcar1; BCAR1_HUMAN; Breast cancer anti estrogen resistance 1; Breast cancer anti-estrogen resistance protein 1; CAS; Cas scaffolding protein family member 1; Crk associated substrate; Crk associated substrate p130Cas; CRK-associated substrate; CRKAS; P130CAS.  
    产品类型 :  磷酸化抗体
    研究领域 :  肿瘤  信号转导  激酶和磷酸酶  
    抗体来源 :  Rabbit
    克隆类型 :  Polyclonal
    交叉反应 :   Human, Mouse, Rat, Horse,
    产品应用 :  ELISA=1:500-1000 IHC-P=1:400-800 IHC-F=1:400-800 IF=1:100-500 (石蜡切片需做抗原修复)
    not yet tested in other applications.
    optimal dilutions/concentrations should be determined by the end user.
     :  93kDa
    细胞定位 :  细胞浆 细胞膜
        :  Lyophilized or Liquid
        :  1mg/ml
     :  KLH conjugated Synthesised phosphopeptide derived from human BCAR1 around the phosphorylation site of Tyr410:GV(p-Y)AV
        :  IgG
    纯化方法 :  affinity purified by Protein A
     :  0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
    保存条件 :  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
    PubMed :  PubMed
    产品介绍background:
    p130 represents one of several known substrates for v-Crk encoded p47. p130 Cas (for Crk-associated substrate) exhibits a high level of tyrosine phosphorylation and is tightly associated with v-Crk, suggesting a role in v-Crk-mediated cell signaling. The molecular cloning of p130 Cas has shown it to represent a novel SH3 containing signaling molecule with a cluster of multiple putative SH2-binding motifs for v-Crk. By immunoprecipitation analysis, p130 Cas has been shown to be highly phosphorylated at tyrosine residues subsequent to either v-Src p60 or v-Crk-mediated transformation and to form stable complexes with both of these transforming proteins. p130 Cas behaves as an extremely potent substrate for protein tyrosine kinases and has been reported to relocate from the cytoplasm to cell membrane upon tyrosine phosphorylation. One proposed model is that the SH2 domain of v-Crk functions to activate c-Src kinase, which in turn phosphorylates p130 Cas.

    Function:
    Docking protein which plays a central coordinating role for tyrosine kinase-based signaling related to cell adhesion. Implicated in induction of cell migration. Overexpression confers antiestrogen resistance on breast cancer cells.

    Subunit:
    Forms complexes in vivo with PTK2/FAK1, adapter protein CRKL and LYN kinase. Can heterodimerize with NEDD9. Interacts with BCAR3, NPHP1 and SH2D3C (By similarity). Interacts with activated CSPG4. Interacts with BMX, INPPL1/SHIP2 and PEAK1. Part of a collagen-stimulated complex involved in cell migration made of CDC42, CRK, TNK2 and BCAR1/p130cas. Interacts with TNK2 via SH3 domains. Interacts with PTK2B/PYK2.

    Subcellular Location:
    Cell junction, focal adhesion. Cytoplasm. Note=Unphosphorylated form localizes in the cytoplasm and can move to the membrane upon tyrosine phosphorylation

    Tissue Specificity:
    Widely expressed with an abundant expression in the testis. Low level of expression seen in the liver, thymus, and peripheral blood leukocytes. The protein has been detected in a B-cell line.

    Post-translational modifications:
    PTK2/FAK1 activation mediates phosphorylation at the YDYVHL motif; phosphorylation is most likely catalyzed by SRC family members. SRC-family kinases are recruited to the phosphorylated sites and can phosphorylate other tyrosine residues. Tyrosine phosphorylation is triggered by integrin-mediated adhesion of cells to the extracellular matrix.

    Similarity:
    Belongs to the CAS family.
    Contains 1 SH3 domain.

    SWISS:
    P56945

    Gene ID:
    9564

    Important Note:
    This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

    产品图片 :  
    磷酸化乳腺癌抗雌激素耐药蛋白1抗体

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥1280
    北京百奥莱博科技有限公司
    2025年07月15日询价
    ¥1580
    上海钦诚生物科技有限公司
    2025年07月16日询价
    ¥1280
    优利科(上海)生命科学有限公司
    2025年07月13日询价
    询价
    上海一研生物科技有限公司
    2025年07月16日询价
    询价
    上海研谨生物科技有限公司
    2025年07月11日询价
    磷酸化乳腺癌抗雌激素耐药蛋白1抗体
    ¥1580